Navigation Links
Federal Funding Awarded to Test Antimicrobial Properties of Copper Metals
Date:8/19/2007

U.S. Dept. of Defense Interested in Copper's Ability to Reduce Threat of

Hospital Infections and Improve Indoor Air Quality

NEW YORK, Aug. 1 /PRNewswire/ -- Congressionally appropriated funds to determine the antimicrobial effectiveness of copper, brass and bronze have been awarded to the Copper Development Association, announced CDA President Andrew G. Kireta Sr.

One study will focus on the ability of copper metals to kill deadly pathogens on touch surfaces in hospital facilities in New York City and Charleston, South Carolina. The other will focus on the effectiveness of copper components in heating, ventilation and air-conditioning systems at Fort Jackson in Columbia, South Carolina; Fort Gordon, in Augusta, Georgia; and the U.S. Air Force Academy in Colorado Springs, Colorado. The studies will be carried out for the U.S. Department of Defense under the aegis of the Telemedicine and Advanced Technologies Research Center (TATRC), a section of the Army Medical Research and Materiel Command (USAMRMC), and implemented by Advanced Technology Institute (ATI).

Recent peer-reviewed research conducted at the University of Southampton in the U.K. proves copper, brass and bronze can quickly and efficiently eradicate several different pathogens which are the source of many hospital- acquired infections, including methicillin-resistant Staphylococcus aureus (MRSA) and Escherichia coli O157:H7. The U.S. Centers for Disease Control and Prevention (CDC) estimates that infections acquired in U.S. hospitals affect some two million individuals every year, resulting in nearly 100,000 deaths annually and costing $30 billion.

Microbial growth on common touch surfaces is of increasing concern to healthcare facilities. According to Dr. Harold Michels, vice president of Technical and Information Services for CDA and the studies' principal investigator, "A positive outcome to these studies will provide hospitals with solid information on an add
'/>"/>

SOURCE Copper Development Association

Copyright©2007 PR Newswire.

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Alzheimers Growth Shows Need for Increased FDA Funding
2. Vastox Awarded £400,000 Grant to Support R&D at Carbohydrate Chemistry Facility
3. July Issue of Journal of Antimicrobial Chemotherapy Highlights Study of Factive Tablets for Five-Day Treatment of Community-Acquired Pneumonia
4. Prolexys Pharmaceuticals and Columbia University Researchers Publish Study on Anti-Tumor Properties of a Selective Small Molecule Anti-Tumor Agent With Novel Mechanism of Action
5. New Data On the Probiotic Strain Bifantis Shows Anti-Inflammatory Properties and Increased Health Benefits
6. Discoverys KL-4 Surfactant Technology Demonstrates Novel Anti-Inflammatory Properties
7. Abraxis BioScience Presents Results from Pre-Clinical Study That Demonstrates nab-Rapamycins Robust Antitumor Properties and Ability to Target Intracellular Sites Such as the mTOR Pathway
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2008)...RT WORTH, Texas, Aug. 26 /- Healthpoi...l trial to evaluate the effectiveness of a,widely ...taneous wounds and,resulting scars. The pilot stud...e reduced incidence of hypertrophic scars and bene...ase SANTYL(R) Ointment.(1,2), "Given the findings...
(Date:8/25/2008)... Discovers Stem Cells Found in Menstrual Blood May...cts for Time-Pressed Women, OLDSMAR, Fla., Aug. 2.... Yet most women would agree that there never seem... a woman spends on doing something just,for hersel...sts in others.,This reality has led many women in ...
(Date:8/25/2008)...t Line CLL, NHL and CLL Retreatment and Japanese D...Planned, COPENHAGEN, Denmark, August 25 /PRNewswi...in four studies of ofatumumab in chronic lymphocyt.../S (OMX: GEN) announced today plans to begin four ...mia (CLL) and follicular,non-Hodgkin,s lymphoma (N...
(Date:8/21/2008)...NHATTAN, Kan., Aug. 21 /PRNewswire-USNewswire/ -- ...E. coli O157:H7 expert T.G. Nagaraja has,been tapp...both the,connection between feeding distillers, gr...ategies to reduce the presence of the naturally oc...eceived a $939,220 National Research Initiative in...
Breaking Medicine Technology:Healthpoint Initiates Randomized, Double-Blind Study to Evaluate Effectiveness of Collagenase SANTYL(R) Ointment on Wound Healing 2Healthpoint Initiates Randomized, Double-Blind Study to Evaluate Effectiveness of Collagenase SANTYL(R) Ointment on Wound Healing 3Going Beyond 'Spa Day': Giving Women the Opportunity to Do Something Proactive Which May Lead to Long Term Health Benefits 2Genmab Announces Upcoming Ofatumumab Studies 2Genmab Announces Upcoming Ofatumumab Studies 3Genmab Announces Upcoming Ofatumumab Studies 4K-State Researchers Awarded Nearly $1 Million to Test Remedies, Investigate Link Between E. Coli and Distillers' Grains 2Dr Amit Dhawan Promoted to Medical Director for The Mattson Jack Group 114 1Dr Amit Dhawan Promoted to Medical Director for The Mattson Jack Group 114 2Dr Amit Dhawan Promoted to Medical Director for The Mattson Jack Group 114 3UK junior doctors gaining less experience of common procedures 115 1UK junior doctors gaining less experience of common procedures 115 2Ancient organisms discovered in Canadian gold mine 110 1Ancient organisms discovered in Canadian gold mine 110 2Survey reveals disparities in skin cancer knowledge protection among high school students 110 1Survey reveals disparities in skin cancer knowledge protection among high school students 110 2Survey reveals disparities in skin cancer knowledge protection among high school students 110 3
... Rexahn,Pharmaceuticals, Inc. (OTC BB:RXHN), a bio... development, and commercialization of,innovative ...rders,sexual dysfunction and other unmet medical ...ncipal Investigator of Phase I clinical,trial of t...n),will present results of the clinical study at ...
...n Transplantation, HORSHOLM, Denmark, May 31, 2007...ces positive Phase I clinical results for,its tran...nto US,Phase II clinical trials for organ transpla...nounces positive results,from its Phase I clinical...aily tacrolimus tablet. , A series of Phase I tria...
Other Medicine Technology:LifeCycle Pharma Announces Positive Phase I Clinical Results for,its Transplantation Product Candidate, LCP-Tacro 2LifeCycle Pharma Announces Positive Phase I Clinical Results for,its Transplantation Product Candidate, LCP-Tacro 3
(Date:8/29/2008)...esults of a 10-year study published in the August ...found that magnesium sulfate administered to women...he risk of cerebral palsy by 50 percent. The Benef...) trial was conducted in 18 centers in the U.S., i...renatal intervention ever found to reduce the inst...
(Date:8/29/2008)... http://www.aronowitzmd.com [Los An...espected experience in plastic surgery procedures ...consideration may be necessary for these patients,...e an established specialty of procedures for after...es, CA (PRWEB) August 29, 2008 -- Bariatric surger...
(Date:8/28/2008)...ues increase 138% versus Q2 2007 - Nine new Cen...RNewswire-FirstCall/ - CRH Medical Corporation,(CR... three and six months,ended June 30, 2008 (all fig...ths ended June 30, 2008 increased 138% to $1,653,8...7. Revenue for the six months ended June,30, 2008 ...
(Date:8/28/2008)...ion will be based in the Northeast region with mor...xt year, HARRISBURG, Pa., Aug. 28 /PRNewswire-USN...ity has hired a Patient Safety Liaison for the,Nor...eport to the,Pennsylvania Patient Safety Reporting...ylvania citizens., "Last year in focus groups wit...
Breaking Medicine News(10 mins):Health News:National study shows magensium sulfate reduces risk of cerebral palsy in premature births 2Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 2Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 3Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 4Health News:CRH Medical reports Q2 2008 results 2Health News:CRH Medical reports Q2 2008 results 3Health News:CRH Medical reports Q2 2008 results 4Health News:CRH Medical reports Q2 2008 results 5Health News:Pennsylvania Patient Safety Authority Hires Patient Safety Liaison to Help Healthcare Facilities Implement Guidance 2Health News:Pennsylvania Patient Safety Authority Hires Patient Safety Liaison to Help Healthcare Facilities Implement Guidance 3
...awa region when the classy gleaming state-of-the-a.../ psychiatric care and research facility was open...uts 188 inpatient beds to public last week. This ...l to be entirely financed and maintained by the pr...
...w symptoms of depression, irascibility, aching joi...st// in sex because of the lack of testosterone, a...found that 52 percent of men between 30 and 40 yea...percent of them say their physical strength and re...
...erapy is becoming the most sought-after treatment ...uty are parlours// and clinics that are offering t...ark circles, flower therapy seems to be the perfec...ers every day," says Neerja, who owns a skin and b...
...for people with Type 2 Diabetes, named ‘Diabetes C...Life Insurance//. Speaking at the inauguration of...urance and Dr.Mohan’s Diabetes Specialties Centre,...ctor, ICICI Prudential Life Insurance, said, "With...
Other Medicine News:
4 mm wide tip.
Double-ended. 3 mm x 5 mm curette end and 3 mm spatula end.
2.5 mm x 4 mm opening. Hexagonal handle.
Double-ended. Sharp and blunt 6.5 mm tips. Designated most popular model or size.
Medicine Products: